文献速递针灸推拿中医内科

针刺治疗偏头痛Meta分析的报告与方法学质量:方法学调查与证据图

Reporting and methodological quality of meta-analyses of acupuncture for patients with migraine: A methodological investigation with evidence map.
PubMed 文献 · J Integr Med · 2022-02-04

该研究系统检索7个数据库至2020年9月,纳入20篇针刺治疗偏头痛的随机对照试验配对Meta分析,用PRISMA 2009和AMSTAR 2评估报告与方法学质量并绘制证据图。纳入Meta分析提示针刺在预防和治疗偏头痛方面有效且安全,报告质量与方法学质量高度相关(rs=0.87,P<0.001),但整体质量欠佳。

要点

  • 针刺预防和治疗偏头痛有效且安全,可考虑作为偏头痛患者的选择。
  • 纳入Meta分析的报告与方法学质量欠佳,需重点改进方案注册、检索策略和证据强度总结。
  • 报告质量与方法学质量高度相关(rs=0.87,P<0.001)。

核心结论

  • 针刺是预防和治疗偏头痛的有效且安全的干预措施,可考虑作为偏头痛患者的一个良好选择。
  • 纳入的Meta分析报告与方法学质量欠佳,未来制作和报告系统评价与Meta分析应遵循AMSTAR 2和PRISMA工具。

研究设计与样本

  • 方法学调查与证据图,检索PubMed、Embase、Cochrane Library、CNKI、CBM、万方和VIP数据库自建库至2020年9月。
  • 纳入针刺或基于针刺疗法治疗偏头痛的随机对照试验配对Meta分析,对照为假针刺、药物、不治疗或不同穴位针刺。
  • 共纳入20篇Meta分析,由两名研究者独立筛选、提取数据并用PRISMA 2009和AMSTAR 2评估质量,结果交叉核对。

主要发现

  • 纳入的Meta分析提示,与对照干预相比,针刺在预防和治疗偏头痛方面有效且安全。
  • 报告质量与方法学质量评分高度相关(rs=0.87,P<0.001)。
  • 纳入系统评价的质量需改进,主要涉及方案与前瞻性注册、全面检索策略、关键结局证据体强度总结、排除研究清单及理由、随机对照试验资金来源报告、评估随机对照试验偏倚风险对Meta分析结果的潜在影响。

关键数值与推荐

  • 报告质量与方法学质量评分高度相关(rs=0.87,P<0.001)。
  • 纳入20篇Meta分析,整体报告与方法学质量欠佳。
  • 质量改进重点包括方案与前瞻性注册、全面检索策略、关键结局证据体强度总结、排除研究清单及理由、随机对照试验资金来源报告、评估偏倚风险对Meta分析结果的潜在影响。

临床怎么用

  • 临床可考虑将针刺作为偏头痛预防和治疗的有效且安全选择。
  • 解读针刺治疗偏头痛的Meta分析证据时,需注意其报告与方法学质量欠佳,应谨慎看待结论。

局限性

  • 纳入的Meta分析报告与方法学质量欠佳,可能影响证据可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acupuncture has been widely used to relieve migraine-related symptoms. However, the findings of previous systematic reviews (SRs) and meta-analyses (MAs) are still not completely consistent. Their quality is also unknown, so a comprehensive study is needed. OBJECTIVE: To evaluate the reporting and methodological quality of these MAs concerning acupuncture for migraine, and summarize evidence about the efficacy and safety of acupuncture for migraine. SEARCH STRATEGY: PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, Chinese Biomedical Databases, Wanfang Data, and VIP databases were searched from inception to September 2020, with a comprehensive search strategy. INCLUSION CRITERIA: The pairwise MAs of randomized controlled trials (RCTs) concerning migraine treated by acupuncture or acupuncture-based therapies, with a control group that received sham acupuncture, medication, no treatment, or acupuncture at different acupoints were included. DATA EXTRACTION AND ANALYSIS: Two independent investigators screened studies, extracted relevant data, and assessed reporting and methodological quality using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2009 and A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2), then all results were cross-checked. Spearman correlation test was used to evaluate the correlation between reporting and methodological quality scores. RESULTS: A total of 20 MAs were included in this study. The included MAs indicated that acupuncture was efficacious and safe in preventing and treating migraine when compared with control intervention. There was a high correlation between reporting and methodological quality scores (rs = 0.87, P < 0.001). The quality of the included SRs needs to be improved mainly with regard to protocol and prospective registration, using a comprehensive search strategy, summarizing the strength of evidence body for key outcomes, a full list of excluded studies with reasons for exclusion, reporting of RCTs' funding sources, and assessing the potential impact of risk of bias in RCTs on MA results. CONCLUSION: Acupuncture is an effective and safe intervention for preventing and treating migraine, and could be considered as a good option for patients with migraine. However, the reporting and methodological quality of MAs included in this overview is suboptimal. In the future, AMSTAR 2 and PRISMA tools should be followed when making and reporting an SR with MA.

来源:J Integr Med,查看原文。版权归原作者所有。

引用

  1. Lu TT, Lu CC, Li MX, et al. Reporting and methodological quality of meta-analyses of acupuncture for patients with migraine: A methodological investigation with evidence map. J Integr Med. 2022. PMID: 35232686. doi:10.1016/j.joim.2022.02.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。